A detailed history of Sym Financial Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Sym Financial Corp holds 6,815 shares of JNJ stock, worth $1.06 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
6,815
Previous 4,689 45.34%
Holding current value
$1.06 Million
Previous $741,000 34.41%
% of portfolio
0.16%
Previous 0.12%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$144.38 - $157.78 $306,951 - $335,440
2,126 Added 45.34%
6,815 $996,000
Q1 2024

May 06, 2024

SELL
$155.22 - $162.74 $197,750 - $207,330
-1,274 Reduced 21.37%
4,689 $741,000
Q4 2023

Feb 06, 2024

BUY
$145.6 - $158.88 $114,587 - $125,038
787 Added 15.2%
5,963 $934,000
Q3 2023

Oct 27, 2023

BUY
$155.75 - $174.48 $806,162 - $903,108
5,176 New
5,176 $806,000
Q1 2023

May 02, 2023

SELL
$151.05 - $180.26 $131,413 - $156,826
-870 Reduced 33.23%
1,748 $270,000
Q3 2022

Oct 28, 2022

SELL
$161.33 - $179.52 $4,678 - $5,206
-29 Reduced 1.1%
2,618 $428,000
Q2 2022

Jul 19, 2022

BUY
$168.19 - $186.01 $12,277 - $13,578
73 Added 2.84%
2,647 $470,000
Q1 2022

Apr 22, 2022

BUY
$158.14 - $179.59 $5,693 - $6,465
36 Added 1.42%
2,574 $456,000
Q4 2021

Feb 03, 2022

SELL
$155.93 - $173.01 $102,913 - $114,186
-660 Reduced 20.64%
2,538 $434,000
Q3 2021

Oct 15, 2021

BUY
$161.5 - $179.47 $46,835 - $52,046
290 Added 9.97%
3,198 $516,000
Q2 2021

Jul 20, 2021

BUY
$159.48 - $171.07 $174,311 - $186,979
1,093 Added 60.22%
2,908 $479,000
Q1 2021

Apr 19, 2021

BUY
$153.07 - $170.48 $13,164 - $14,661
86 Added 4.97%
1,815 $298,000
Q4 2020

Jan 26, 2021

BUY
$137.11 - $157.38 $8,500 - $9,757
62 Added 3.72%
1,729 $272,000
Q3 2020

Oct 13, 2020

BUY
$140.38 - $153.83 $1,544 - $1,692
11 Added 0.66%
1,667 $248,000
Q2 2020

Jul 27, 2020

SELL
$128.81 - $155.51 $24,860 - $30,013
-193 Reduced 10.44%
1,656 $233,000
Q1 2020

Apr 28, 2020

SELL
$111.14 - $153.99 $42,566 - $58,978
-383 Reduced 17.16%
1,849 $242,000
Q4 2019

Feb 11, 2020

BUY
$127.5 - $146.44 $22,312 - $25,627
175 Added 8.51%
2,232 $326,000
Q3 2019

Nov 04, 2019

SELL
$126.95 - $142.14 $18,788 - $21,036
-148 Reduced 6.71%
2,057 $266,000
Q2 2019

Jul 29, 2019

BUY
$131.15 - $144.24 $27,016 - $29,713
206 Added 10.31%
2,205 $307,000
Q1 2019

May 14, 2019

SELL
$125.72 - $139.79 $76,312 - $84,852
-607 Reduced 23.29%
1,999 $279,000
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $168,045 - $202,245
-1,368 Reduced 34.42%
2,606 $336,000
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $218,114 - $256,326
1,794 Added 82.29%
3,974 $549,000
Q2 2018

Aug 13, 2018

BUY
$119.4 - $131.76 $17,313 - $19,105
145 Added 7.13%
2,180 $264,000
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $12,885 - $15,258
103 Added 5.33%
2,035 $261,000
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $253,517 - $277,473
1,932
1,932 $270,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Sym Financial Corp Portfolio

Follow Sym Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sym Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sym Financial Corp with notifications on news.